-65%

est. 2Y upside i

HealthcareSeries C

Rank

#3088

Sector

Pet Healthcare

Est. Liquidity

~3Y

Data Quality

Data: High

Vetic presents a risky equity opportunity with a moderate expected upside, primarily driven by its impressive ~375% YoY revenue growth in a large and expanding Indian pet care market.

Last updated: March 10, 2026

Bull (30%)+150%

Vetic successfully expands its tech-enabled clinic network across major Indian cities, leveraging its mobile app for superior customer experience and capturing significant market share from fragmented local players. Revenue scales to over $30M by 2028, justifying a $280M+ valuation at a healthy multiple, driven by strong unit economics and continued high growth.

Base (25%)+25%

Vetic continues its growth trajectory, but faces increasing competition from Supertails and the entry of global incumbents like Mars. It maintains its market position in key regions, growing revenue to ~$15M by 2028, leading to a modest valuation increase to around $140M, primarily driven by market expansion rather than multiple expansion.

Bear (45%)-60%

Intense competition, particularly from well-funded Supertails and global player Mars, combined with high operational burn and capital requirements for expansion, leads to slower-than-expected growth and continued significant losses. This results in a down round or a flat exit at a valuation of ~$45M, severely impacting common stock value due to the existing $45M liquidation preference.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

40%

Investors hold $45M in liquidation preferences ahead of common stock. In an exit at or below the current $113M valuation, employees with common stock may receive little or nothing after these preferences are paid out.

Dilution Risk

high

Given current unprofitability and expansion plans, Vetic will likely require additional funding rounds, leading to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Vetic's equity.

Questions to Ask at the Interview

Strategic questions based on Vetic's data — designed to show you've done your homework.

  • 1

    “How does Vetic plan to differentiate and compete effectively against well-funded local players like Supertails and the recent entry of global giants like Mars Inc. into the Indian market, particularly concerning clinic expansion and integrated services?”

  • 2

    “Given the current burn rate (INR 40.2 crore net loss in FY24) and capital requirements for clinic expansion, what is the company's detailed roadmap to profitability, and how many more funding rounds are anticipated before a potential liquidity event?”

  • 3

    “Considering the Series C funding and the significant liquidation preference, what is the company's strategy for ensuring meaningful returns for common stock holders in a future exit, and what is the estimated timeline for such an event?”

Community

Valuation Sentiment

Our model estimates -65% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.